Biocryst Pharmaceuticals Stock Overlap Studies Triple Exponential Moving Average

BCRX Stock  USD 7.60  0.11  1.47%   
BioCryst Pharmaceuticals overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against BioCryst Pharmaceuticals. BioCryst Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. BioCryst Pharmaceuticals overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was six with a total number of output elements of fifty-five. BioCryst Pharmaceuticals Triple Exponential Moving Average indicator shows smoothing effect of BioCryst Pharmaceuticals price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

BioCryst Pharmaceuticals Technical Analysis Modules

Most technical analysis of BioCryst Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioCryst from various momentum indicators to cycle indicators. When you analyze BioCryst charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About BioCryst Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioCryst Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioCryst Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing BioCryst Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioCryst Pharmaceuticals's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BioCryst Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for BioCryst Pharmaceuticals, we also check how macroeconomic factors affect BioCryst Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number12.4815.37.936.31
Receivables Turnover5.345.355.822.98
Hype
Prediction
LowEstimatedHigh
4.427.5810.74
Details
Intrinsic
Valuation
LowRealHigh
6.379.5312.69
Details
Naive
Forecast
LowNextHigh
4.297.4510.61
Details
11 Analysts
Consensus
LowTargetHigh
13.8315.2016.87
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioCryst Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioCryst Pharmaceuticals' short interest history, or implied volatility extrapolated from BioCryst Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Blockchain Idea
Blockchain
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Business Services Idea
Business Services
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares

Additional Tools for BioCryst Stock Analysis

When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.